Abstract:Chemotherapy resistance is one of the major reasons for treatment failure and tumour recurrence in colorectal cancer. Recent studies indicate that cancer stem cells (CSCs) are responsible for chemotherapy resistance. This study aims to establish a stemness-related gene signature for predicting the prognosis of colorectal cancer patients with adjuvant chemotherapy. Two independent cohorts with complete gene expression profiles, adjuvant chemotherapy and survival information were included. GSE39582 (n = 566) was used as the training cohort and TCGA (n = 624) as the validation cohort. 233 patients from GSE39582 and 231 patients from TCGA with complete gene expression profiles, adjuvant chemotherapy and survival information were finally included in our study, respectively. Nine widely recognized CSC markers were used to identify stemness-related genes from the protein-protein interaction database (BioGRID). Candidate genes were further filtered by Cox regression with bootstrap and then LASSO Cox was used to construct the prognostic model. Univariate and multivariate analyses were conducted to evaluate the prognostic value of the model. Pathway analysis was conducted between the risk groups for functional study. We constructed a 10-gene signature and divided patients into two groups using an optimal cut-off determined using time-dependent ROC analysis. The Kaplan-Meier curves showed that patients in the high-risk group had a significantly poorer 5-year disease-free survival (DFS) than those in the low-risk group (training cohort: hazard ratio (HR)=2.41[1.58-3.66], P < 0.001; validation cohort: HR=1.82[1.17-2.83], P < 0.001). More importantly, the 10-gene signature could also robustly stratify stage II and III patients into high- and low-risk groups (training cohort: HR=2.61[1.62-4.23], P < 0.001; validation cohort: HR=1.87[1.03-3.40], P=0.037). Multivariate analysis showed that the 10-gene signature was an independent prognostic factor for colorectal cancer patients with adjuvant therapy (training cohort: HR=1.94[1.23-3.08], P < 0.001; validation cohort: HR=1.66[1.06-2.61], P = 0.027). Functional analysis showed that several pathways were dysregulated in the high-risk group, including EMT, myogenesis and KRAS signalling. The stemness-related gene signature is a robust predictive tool for colorectal cancer. Patients in the high-risk group may not be suitable for chemotherapy due to a higher risk of chemotherapy resistance.

Characteristic Analysis of Featured Genes Associated With Stemness Indices in Colorectal Cancer

Stem Cell Landscape Aids in Tumor Microenvironment Identification and Selection of Therapeutic Agents in Gastric Cancer.

Identification of a Cancer Stem Cells Signature of Head and Neck Squamous Cell Carcinoma

Identification of Key Genes Controlling Breast Cancer Stem Cell Characteristics Via Stemness Indices Analysis

Coexpression Network Analysis of Genes Related to the Characteristics of Tumor Stemness in Triple-Negative Breast Cancer

Cancer Stem Cell Associated Eight Gene-Based Signature Predicts Clinical Outcomes of Colorectal Cancer

Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer

Identification of key gene modules and genes in colorectal cancer by co-expression analysis weighted gene co-expression network analysis

Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options

Comprehensive Analysis Reveals A Four-Gene Signature In Colorectal Cancer

Assessing the prognostic value of stemness-related genes in breast cancer patients

Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index

Identification Hub Genes in Colorectal Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Clinical Validation in Vivo and Vitro.

The role of the stemness index-associated signature in the analysis of the tumorigenesis of liver cancer patients of different races

Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma

Stemness Related Genes Revealed by Network Analysis Associated With Tumor Immune Microenvironment and the Clinical Outcome in Lung Adenocarcinoma

Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma

Identification of Hub Genes in Colorectal Cancer Based on Weighted Gene Co-Expression Network Analysis and Clinical Data from the Cancer Genome Atlas

414P Identification of a Stemness-Related Gene Signature for Predicting Prognosis of Patients with Adjuvant Chemotherapy in Colorectal Cancer

Identification and Verification of Core Genes in Colorectal Cancer

Colorectal Cancer Stem Cell States Uncovered by Simultaneous Single‐Cell Analysis of Transcriptome and Telomeres